Kidney Disease Clinical Trials in San Antonio

Showing 261-280 of 284 trials

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

NCT00060307

This phase II trial is studying how well erlotinib works in treating patients with locally advanced or metastatic papillary renal cell (kidney) cancer. Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth

Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer

National Cancer Institute (NCI)40 participantsStarted May 2003

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00101114

This phase II trial is studying how well giving sorafenib with interferon alfa works in treating patients with metastatic or unresectable kidney cancer. Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Interferon alfa may interfere with the growth of tumor cells and slow the growth of kidney cancer. Sorafenib may help interferon alfa work better by making tumor cells more sensitive to the drug

Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more

National Cancer Institute (NCI)55 participantsStarted Sep 2004

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

NCT00597753

The purpose of the study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.

Chronic Renal FailureChronic Kidney DiseaseAnemia

Affymax803 participantsStarted Sep 2007

Paragould, Arkansas, United States • Fairfield, California, United States • Granada Hills, California, United States +86 more locations

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Kidney Disease Trials in Other Cities

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Optimizing Prograf® Therapy in Renal Transplant Patients

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Other Conditions in San Antonio